Clinical Trial Update: Sustainable Early Episode Clinic Study (SEEC) [NA]

View source ↗

Summary

Janssen-sponsored clinical trial SEEC for schizophrenia and schizoaffective disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: Janssen Scientific Affairs, LLC | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED